Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2-controlled regulatory T cell and increase of IL-21-mediated effector T cell expansion.
- Publisher:
- AMER ASSOC IMMUNOLOGISTS
- Publication Type:
- Journal Article
- Citation:
- Journal of immunology (Baltimore, Md. : 1950), 2014, 193, (10), pp. 4845-4858
- Issue Date:
- 2014-11
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2 - controlled regulatory T cell and increase of IL-21 mediated effector T cell expression.pdf | Published version | 1.9 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Chevalier, N | |
dc.contributor.author | Thorburn, AN | |
dc.contributor.author | Macia, L | |
dc.contributor.author | Tan, J | |
dc.contributor.author | Juglair, L | |
dc.contributor.author | Yagita, H | |
dc.contributor.author | Yu, D | |
dc.contributor.author | Hansbro, PM | |
dc.contributor.author | Mackay, CR | |
dc.date.accessioned | 2021-03-03T05:38:50Z | |
dc.date.available | 2021-03-03T05:38:50Z | |
dc.date.issued | 2014-11 | |
dc.identifier.citation | Journal of immunology (Baltimore, Md. : 1950), 2014, 193, (10), pp. 4845-4858 | |
dc.identifier.issn | 0022-1767 | |
dc.identifier.issn | 1550-6606 | |
dc.identifier.uri | http://hdl.handle.net/10453/146724 | |
dc.description.abstract | The dynamic interplay between regulatory T cells (T(regs)) and effector T cells (T(effs)) governs the balance between tolerance and effector immune responses. Perturbations of T(reg) frequency and function or imbalances in T(reg)/T(eff) levels are associated with the development of autoimmunity. The factors that mediate these changes remain poorly understood and were investigated in this study in murine autoimmune arthritis. T(regs) displayed a stable phenotype in arthritic mice and were fully functional in in vitro suppression assays. However, their expansion was delayed relative to T(effs) (T follicular helper cells and Th17 cells) during the early stages of autoimmune reactivity. This imbalance is likely to have led to insufficient T(reg) control of T(effs) and induced autoimmunity. Moreover, a counterregulatory and probably IL-7-driven increase in thymic T(reg) production and recruitment to inflamed tissues was too slow for disease prevention. Increased T(eff) over T(reg) expansion was further aggravated by inflammation and lymphopenia. Both these conditions contribute to autoimmune pathogenesis and were accompanied by decreases in the availability of IL-2 and increases in levels of IL-21. IL-2 neutralization or supplementation was used to show that T(reg) expansion mainly depended on this cytokine. IL-21R(-/-) cells were used to demonstrate that IL-21 promoted the maintenance of T(effs). Thus, at inflammatory sites in experimental arthritis, a deficit in IL-2 hampers T(reg) proliferation, whereas exaggerated IL-21 levels overwhelm T(reg) control by supporting T(eff) expansion. This identifies IL-2 and IL-21 as targets for manipulation in therapies for autoimmunity. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | AMER ASSOC IMMUNOLOGISTS | |
dc.relation.ispartof | Journal of immunology (Baltimore, Md. : 1950) | |
dc.relation.isbasedon | 10.4049/jimmunol.1302966 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1107 Immunology | |
dc.subject.classification | Immunology | |
dc.subject.mesh | T-Lymphocytes, Helper-Inducer | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Mice, Transgenic | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Arthritis | |
dc.subject.mesh | Lymphopenia | |
dc.subject.mesh | Inflammation | |
dc.subject.mesh | Interleukins | |
dc.subject.mesh | Interleukin-2 | |
dc.subject.mesh | Signal Transduction | |
dc.subject.mesh | Cell Proliferation | |
dc.subject.mesh | Autoimmunity | |
dc.subject.mesh | Immune Tolerance | |
dc.subject.mesh | Gene Expression Regulation | |
dc.subject.mesh | T-Lymphocytes, Regulatory | |
dc.subject.mesh | Receptors, Interleukin-21 | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Arthritis | |
dc.subject.mesh | Autoimmunity | |
dc.subject.mesh | Cell Proliferation | |
dc.subject.mesh | Gene Expression Regulation | |
dc.subject.mesh | Immune Tolerance | |
dc.subject.mesh | Inflammation | |
dc.subject.mesh | Interleukin-2 | |
dc.subject.mesh | Interleukins | |
dc.subject.mesh | Lymphopenia | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Mice, Transgenic | |
dc.subject.mesh | Receptors, Interleukin-21 | |
dc.subject.mesh | Signal Transduction | |
dc.subject.mesh | T-Lymphocytes, Helper-Inducer | |
dc.subject.mesh | T-Lymphocytes, Regulatory | |
dc.title | Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2-controlled regulatory T cell and increase of IL-21-mediated effector T cell expansion. | |
dc.type | Journal Article | |
utslib.citation.volume | 193 | |
utslib.location.activity | United States | |
utslib.for | 1107 Immunology | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science/School of Life Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2021-03-03T05:38:46Z | |
pubs.issue | 10 | |
pubs.publication-status | Published | |
pubs.volume | 193 | |
utslib.citation.issue | 10 |
Abstract:
The dynamic interplay between regulatory T cells (T(regs)) and effector T cells (T(effs)) governs the balance between tolerance and effector immune responses. Perturbations of T(reg) frequency and function or imbalances in T(reg)/T(eff) levels are associated with the development of autoimmunity. The factors that mediate these changes remain poorly understood and were investigated in this study in murine autoimmune arthritis. T(regs) displayed a stable phenotype in arthritic mice and were fully functional in in vitro suppression assays. However, their expansion was delayed relative to T(effs) (T follicular helper cells and Th17 cells) during the early stages of autoimmune reactivity. This imbalance is likely to have led to insufficient T(reg) control of T(effs) and induced autoimmunity. Moreover, a counterregulatory and probably IL-7-driven increase in thymic T(reg) production and recruitment to inflamed tissues was too slow for disease prevention. Increased T(eff) over T(reg) expansion was further aggravated by inflammation and lymphopenia. Both these conditions contribute to autoimmune pathogenesis and were accompanied by decreases in the availability of IL-2 and increases in levels of IL-21. IL-2 neutralization or supplementation was used to show that T(reg) expansion mainly depended on this cytokine. IL-21R(-/-) cells were used to demonstrate that IL-21 promoted the maintenance of T(effs). Thus, at inflammatory sites in experimental arthritis, a deficit in IL-2 hampers T(reg) proliferation, whereas exaggerated IL-21 levels overwhelm T(reg) control by supporting T(eff) expansion. This identifies IL-2 and IL-21 as targets for manipulation in therapies for autoimmunity.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph